Long noncoding RNAs in urine are detectable and may enable early detection of acute T cell-mediated rejection of renal allografts

Clinical Chemistry

Volumn 61, Issue 12, 2015, Pages 1505-1514

  Lorenzen, Johan M ^a   Schauerte, Celina ^a   Kölling, Malte ^a   Hübner, Anika ^a   Knapp, Monika ^a   Haller, Hermann ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CREATININE; INTERLEUKIN 6; LONG UNTRANSLATED RNA; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY DIAGNOSIS; ENZYME ACTIVATION; FEMALE; GENETIC ANALYZER; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; LONG UNTRANSLATED RNA URINE LEVEL; MALE; MICROENVIRONMENT; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION SYSTEM; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN URINE LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; RNA ISOLATION; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE MEDIATED RENAL ALLOGRAFT REJECTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; URINALYSIS; ACUTE DISEASE; ACUTE KIDNEY INJURY; ADOLESCENT; CELL CULTURE; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SECRETION (PROCESS); URINE;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; BIOMARKERS; CELLS, CULTURED; COHORT STUDIES; EARLY DIAGNOSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; INTERLEUKIN-6; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING;

EID: 84948664594     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.243600     Document Type: Article

References (22)

1. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993;55:752-6.
2. Hardinger KL and Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013;3:68-77.
3. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004;78:242-9.
4. Moreso F, Ibernon M, Gomà M, Carrera M, Fulladosa X, Hueso M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006;6: 747-52.
5. Sanjevani S, Pruthi S, Kalra S, Goel A, Kalra OP. Role of neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury. Int J Crit Illn Inj Sci 2014; 4:223-8.
6. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
7. Lorenzen JM, Haller H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 2011;7:286-94.
8. Lorenzen JM, Martino F, Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012; 107:245.
9. Hu W, Alvarez-Dominguez JR, Lodish HF. Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep 2012;13:971-83.
10. Lorenzen JM, Schauerte C, Kielstein JT, Hübner A, Martino F, Fiedler J, et al. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin Chem 2015;61: 191-201.
11. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, et al. Banff '09 Meeting Report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2009;10:464-71.
12. Gwinner W. Renal transplant rejection markers. World J Urol 2007;25:445-55.
13. Huang YS, Hsieh HY, Shih HM, Sytwu HK, Wu CC. Urinary Xist is a potential biomarker for membranous nephropathy. Biochem Biophys Res Commun 2014;452: 415-21.
14. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993; 365:764-7.
15. Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med 2015;19:1418-25.
16. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010;584:4575-80.
17. Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014;114:1389-97.
18. Chen F, Tian Y, Pang EJ, Wang Y, Li L. MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther [Epub ahead of print 2015 Feb 27].
19. Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y, et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 2014;5: 11091-102.
20. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 2014;114:1569-75.
21. de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002;62:2695-8.
22. Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-15; discussion 15-6.